Extended Report
Repair of erosions occurs almost exclusively in damaged joints without swelling
1 Lapeyronie Hospital Montpellier, France;
2 Leiden University Medical Center, Netherlands;
3 Wyeth Research, United States;
4 University of Maastricht, Netherlands
Correspondence to: cedric lukas, University Maastricht and CAPHRI Institute, P.O. Box 5800, Maastricht, 6202 AZ, Netherlands; cedriclukas{at}voila.fr
Accepted 3 October 2009
Objective: Negative radiographic change scores obtained under blinded time-sequence conditions suggest that repair of joints may indeed occur. It is likely that - C if it truly exists - C repair would be preferentially seen in clinically inactive joints from patients treated with drugs with well known structural efficacy.
Patients and methods: Radiographs from patients of the TEMPO trial were scored twice by two readers according to the Sharp/van der Heijde score, blinded to both treatment and true time sequence. Single-joint change scores in erosions were coupled with single joint swelling scores obtained from clinical examination. Consistency of observed improvement across readers and repeat reads was described, and factors expected to increase the likelihood of occurrence of both worsening and improvement of erosion were tested by GEE modelling.
Results: In every of the 4 independent reads, the mean change in erosion score was statistically significantly negative only in the subgroup of joints with absent or improved swelling, when erosions were present at baseline. Multivariate analysis showed that worsening of erosion score in a joint was significantly increased if that joint was already damaged at study entry, clinical swelling persisted, and methotrexate was used instead of etanercept. Repair was associated with improvement of swelling and use of etanercept (p
0.007 for all associations).
Conclusion: Repair of erosions almost exclusively occurs in joints with improvement or absence of swelling, in patients treated with etanercept. Progression is seen more frequently in joints with persistent swelling, in patients receiving methotrexate monotherapy, primarily if damage is already present.
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
